NEET MDS Lessons
General Pathology
Biochemical examination
This is a method by which the metabolic disturbances of disease are investigated by assay of various normal and abnormal compounds in the blood, urine, etc.
Pleural effusion is a medical condition where fluid accumulates in the pleural cavity which surrounds the lungs, making it hard to breathe.
Four main types of fluids can accumulate in the pleural space:
Serous fluid (hydrothorax)
Blood (hemothorax)
Lipid (chylothorax)
Pus (pyothorax or empyema)
Causes:
Pleural effusion can result from reasons such as:
- Cancer, including lung cancer or breast cancer
- Infection such as pneumonia or tuberculosis
- Autoimmune disease such as lupus erythematosus
- Heart failure
- Bleeding, often due to chest trauma (hemothorax)
- Low oncotic pressure of the blood plasma
- lymphatic obstruction
- Accidental infusion of fluids
Congestive heart failure, bacterial pneumonia and lung cancer constitute the vast majority of causes in the developed countries, although tuberculosis is a common cause in the developing world.
Diagnosis:
- Gram stain and culture - identifies bacterial infections
- Cell count and differential - differentiates exudative from transudative effusions
- Cytology - identifies cancer cells, may also identify some infective organisms
- Chemical composition including protein, lactate dehydrogenase, amylase, pH and glucose - differentiates exudative from transudative effusions
- Other tests as suggested by the clinical situation - lipids, fungal culture, viral culture, specific immunoglobulins
THROMBOSIS
Pathogenesis (called Virchow's triad):
1. Endothelial* Injury ( Heart, Arteries)
2. Stasis
3. Blood Hypercoagulability
- Endothelial cells are special type of cells that cover the inside surface of blood vessels and heart.
CONTRIBUTION OF ENDOTHELIAL CELLS TO COAGULATION
Intact endothelial cells maintain liquid blood flow by:
1- inhibiting platelet adherence
2- preventing coagulation factor activation
3- lysing blood clots that may form.
Endothelial cells can be stimulated by direct injury or by various cytokines that are produced during inflammation.
Endothelial injury results in:
1- expression of procoagulant proteins (tissue factor and vWF)→ local thrombus formation.
2- exposure of underlying vWF and basement membrane collagen → platelet aggregation and thrombus formation.
RESPONSE OF VASCULAR WALL CELLS TO INJURY( PATHOLOGIC EFFECT OF VASCULAR HEALING)
Injury to the vessel wall results in a healing response, involving:
- Intimal expansion (proliferating SMCs and newly synthesized ECM). This involves signals from ECs, platelets, and macrophages; and mediators derived from coagulation and complement cascades.
- luminal stenosis & blockage of vascular flow
Causes of Endothelial injury
1. Valvulitis
2. MI
3. Atherosclerosis
4. Traumatic or inflammatory conditions
5. Increased Blood Pressure
6. Endotoxins
7. Hypercholesterolemia
8. Radiation
9. Smoking
Stasis
- Stasis is a major factor in venous thrombi
- Normal blood flow is laminar (platelets flow centrally in the vessel lumen, separated from the endothelium by a slower moving clear zone of
plasma)
- Stasis and turbulence cause the followings:
Disuption of normal blood flow
prevent dilution of activated clotting factor
retard inflow of clotting factor inhibitor
promote endothelial cell injury
Causes of Stasis
1. Atherosclerosis
2. Aneurysms
3. Myocardial Infarction ( Non-cotractile fibers)
4. Mitral valve stenosis (atrial dilation)
5. Hyper viscosity syndromes (PCV and Sickle Cell anemia)
Hypercoagulability
A. Genetic (primary):
- mutations in the factor V gene and the prothrombin gene are the most common
B. Acquired (secondary):
- multifactorial and more complicated
- causes include: Immobilization, MI, AF, surgery, fracture, burns, Cancer, Prosthetic cardiac valves
MORPHOLOGY OF THROMBI
Can develop anywhere in the CVS (e.g., in cardiac chambers, valves, arteries, veins, or capillaries).
Arterial or cardiac thrombi→ begin at sites of endothelial injury; and are usually superimposed on an atherosclerotic plaque.
Venous thrombi → occur at sites of stasis. Most commonly the veins of the lower extremities (90%)
Thrombi are focally attached to the underlying vascular surface; arterial and venous thrombi both tend to propagate toward the heart.
→ The propagating portion of a thrombus is poorly attached → fragmentation and embolus formation
LINES OF ZAHN
Thrombi can have grossly (and microscopically) apparent laminations called lines of Zahn; these represent pale platelet and fibrin layers alternating with darker erythrocyte-rich layers.
Such lines are significant in that they represent thrombosis of flowing blood.
Mural thrombi = Thrombi occurring in heart chambers or in the aortic lumen.
Causes: -Abnormal myocardial contraction (e.g. arrhythmias, dilated cardiomyopathy, or MI) -endomyocardial injury (e.g. myocarditis, catheter trauma)
Vegetations ->Thrombi on heart valves
1- Bacterial or fungal blood-borne infections - (infective endocarditis,).
2- Non-bacterial thrombotic endocarditis occur on sterile valves.
Fate of thrombi
1. Propagation → Thrombi accumulate additional platelets and fibrin, eventually causing vessel obstruction
2. Embolization → Thrombi dislodge or fragment and are transported elsewhere in the vasculature
3. Dissolution → Thrombi are removed by fibrinolytic activity (Usually in recent thrombi)
4. Organization and recanalization → Thrombi induce inflammation and fibrosis. - recanalization (re-establishing some degree of flow) - Organization = ingrowth of endothelial cells, smooth cells and fibroblasts into the fibrin rich thrombus.
5. Superimposed infection (Mycotic aneurysm)
Venous thrombi → most common in veins of the legs
a. Superficial: e.g. Saphenous veins. - can cause local congestion, swelling, pain, and tenderness along the course of the involved vein, but they rarely embolize
a. Deep: e.g. Popliteal, Femoral and iliac vein. - more serious because they may embolize - can occur with stasis or hypercoagulable states
Emphysema
Emphysema is a chronic lung disease. It is often caused by exposure to toxic chemicals or long-term exposure to tobacco smoke.
Signs and symptoms
loss of elasticity of the lung tissue
destruction of structures supporting the alveoli
destruction of capillaries feeding the alveoli
The result is that the small airways collapse during expiration, leading to an obstructive form of lung disease
Features are: shortness of breath on exertion
hyperventilation and an expanded chest.
As emphysema progresses, clubbing of the fingers may be observed, a feature of longstanding hypoxia.
Emphysema patients are sometimes referred to as "pink puffers". This is because emphysema sufferers may hyperventilate to maintain adequate blood oxygen levels. Hyperventilation explains why emphysema patients do not appear cyanotic as chronic bronchitis (another COPD disorder) sufferers often do; hence they are "pink" puffers (adequate oxygen levels in the blood) and not "blue" bloaters (cyanosis; inadequate oxygen in the blood).
Diagnosis
spirometry (lung function testing), including diffusion testing
X-rays, high resolution spiral chest CT-scan,
Bronchoscopy, blood tests, pulse oximetry and arterial blood gas sampling.
Pathophysiology :
Permanent destructive enlargement of the airspaces distal to the terminal bronchioles without obvious fibrosis
Oxygen is inhaled in normal breathing
When toxins such as smoke are breathed into the lungs, the particles are trapped by the hairs and cannot be exhaled, leading to a localised inflammatory response. Chemicals released during the inflammatory response (trypsin, elastase, etc.) are released and begin breaking down the walls of alveoli. This leads to fewer but larger alveoli, with a decreased surface area and a decreased ability to take up oxygen and loose carbon dioxide. The activity of another molecule called alpha 1-antitrypsin normally neutralizes the destructive action of one of these damaging molecules.
After a prolonged period, hyperventilation becomes inadequate to maintain high enough oxygen levels in the blood, and the body compensates by vasoconstricting appropriate vessels. This leads to pulmonary hypertension. This leads to enlargement and increased strain on the right side of the heart, which in turn leads to peripheral edema (swelling of the peripherals) as blood gets backed up in the systemic circulation, causing fluid to leave the circulatory system and accumulate in the tissues.
Emphysema occurs in a higher proportion in patient with decreased alpha 1-antitrypsin (A1AT) levels
Prognosis and treatment
Emphysema is an irreversible degenerative condition
Supportive treatmentis by supporting the breathing with anticholinergics, bronchodilators and (inhaled or oral) steroid medication, and supplemental oxygen as required
Lung volume reduction surgery (LVRS) can improve the quality of life for only selected patients.
Urinary tract infection
Most often caused by gram-negative, rod-shaped bacteria that are normal residents of the enteric tract, especially Escherichia coli.
Clinical manifestations:
frequent urination, dysuria, pyuria (increased PMNs), hematuria, and bacteriuria.
May lead to infection of the urinary bladder (cystitis) or kidney (pyelonephritis).
STREPTOCOCCAL INFECTIONS
Most streptococci are normal flora of oropharynx
Group A streptococci: Str. pyogenes
Group B streptococci: Str. agalactiae
Str. pneumoniae
Strep viridans group
Group D: Enterococcus (lately Strep. Fecalis and E. fecium), causes urinary tract infections,
Acute viral hepatitis
Clinical features. Acute viral hepatitis may be icteric or anicteric. Symptoms include malaise, anorexia, fever, nausea, upper abdominal pain, and hepatomegaly, followed by jaundice, putty-colored stools, and dark urine.
In HBV, patients may have urticaria, arthralgias, arthritis, vasculitis, and glomerulonephritis (because of circulating immune complexes). Blood tests show elevated serum bilirubin (if icteric), elevated transaminases, and alkaline phosphatase.
The acute illness usually lasts 4-6 weeks.
Pathology
(1) Grossly, there is an enlarged liver with a tense capsule.
(2) Microscopically, there is ballooning degeneration of hepatocytes and liver cell necrosis.